alexa Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease.
Immunology

Immunology

Journal of Clinical & Cellular Immunology

Author(s): Mason A, Wong SC, McGrogan P, Ahmed SF

Abstract Share this page

Abstract BACKGROUND: pubertal delay and growth retardation are common in children with inflammatory bowel disease (IBD). AIMS: To assess pubertal status and growth in a group of boys with IBD undergoing testosterone therapy for pubertal induction. METHODS: retrospective study of height, weight and pubertal status in 8 boys with IBD before and after testosterone therapy. Height velocity (HV) over the 6 months before each assessment was converted to standard deviation score. Markers of disease activity and concomitant medication were recorded. Response was based on an advance in pubertal status and a greater than 50\% increase in HV. RESULTS: eight boys with IBD, median age 14.8 years, had pubertal induction using either monthly injections of 50 mg Sustanon or daily 2.5/5 mg Andropatch. Seven boys showed an advance of pubertal status. Six boys had a greater than 50\% increase in HV; median HV at T0 was 1.6 cm/year (0, 5) compared with 6.9 cm/year (1, 11.7) at T6 (p = 0.005). C-reactive protein during testosterone therapy had a significant association with HV at T6 (r = -0.786; p = 0.021). CONCLUSION: in most cases, testosterone therapy in boys with IBD and delayed growth and puberty is associated with an advance in pubertal status and an improvement in growth. 2010 S. Karger AG, Basel. This article was published in Horm Res Paediatr and referenced in Journal of Clinical & Cellular Immunology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords